Faculty Mentor

Dr. Elaine Vanterpool

Files

Download

Download Full Text (1.1 MB)

Description

Myeloproliferative syndrome (MPS) are rare blood cancers that originate from an abnormal mutation in a stem cell within the bone marrow, leading to excessive production of red blood cells, white blood cells, or platelets. These disorders affect approximately 20,000 individuals annually in the United States, with around 295,000 people currently living with the condition. The purpose of this study is to identify and assess the pathogenicity of GATA1 gene variants associated with MPS.

Publication Date

2025

City

Huntsville

Disciplines

Biology

GATA1 Gene Variants Associated with Myeloproliferative  Syndrome and its impact on Hematopoiesis

Included in

Biology Commons

Share

 
COinS